TW228520B - - Google Patents

Info

Publication number: TW228520B
Authority: TW; Taiwan
Prior art keywords: chem; formula; composition containing; same; gastrointestinal tract
Prior art date: 1990-10-16

Application number

TW080108020A

Other languages

Original Assignee

Teikoku Hormone Mfg Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-10-16

Filing date

1991-10-11

Publication date

1994-08-21

1991-10-11 Application filed by Teikoku Hormone Mfg Co Ltd filed Critical Teikoku Hormone Mfg Co Ltd

1994-08-21 Application granted granted Critical

1994-08-21 Publication of TW228520B publication Critical patent/TW228520B/zh

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyrrole Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)

TW080108020A 1990-10-16 1991-10-11 TW228520B (zh)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP27797690		1990-10-16

Publications (1)

Publication Number	Publication Date
TW228520B true TW228520B (zh)	1994-08-21

Family

ID=17590893

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW080108020A TW228520B (zh)	1990-10-16	1991-10-11

Country Status (9)

Country	Link
US (1)	US5143935A (zh)
EP (1)	EP0481756B1 (zh)
JP (1)	JP2529912B2 (zh)
KR (1)	KR100209118B1 (zh)
AT (1)	ATE155127T1 (zh)
DE (1)	DE69126758T2 (zh)
DK (1)	DK0481756T3 (zh)
ES (1)	ES2106058T3 (zh)
TW (1)	TW228520B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU7665694A (en) *	1993-09-21	1995-04-10	Yamanouchi Pharmaceutical Co., Ltd.	N-(3-pyrrolidinyl)benzamide derivative
KR100333501B1 (ko) *	2000-01-19	2002-04-25	박호군	벤즈아미드 화합물 및 그 제조방법
EP1547593A4 (en) *	2002-09-12	2009-12-23	Nagase Chemtex Corp	MEDICINAL COMPOSITION
JP4760139B2 (ja) *	2004-05-28	2011-08-31	田辺三菱製薬株式会社	ピロリジン誘導体およびその製法
TW200602314A (en) *	2004-05-28	2006-01-16	Tanabe Seiyaku Co	A novel pyrrolidine compound and a process for preparing the same
KR100881040B1 (ko) *	2005-03-11	2009-02-05	나가세케무텍쿠스가부시키가이샤	의약 조성물
JP4943826B2 (ja) *	2005-11-25	2012-05-30	田辺三菱製薬株式会社	医薬組成物
JP2010031063A (ja) *	2009-11-18	2010-02-12	Nagase Chemtex Corp	医薬組成物
TWI808055B (zh)	2016-05-11	2023-07-11	美商滬亞生物國際有限公司	Hdac 抑制劑與 pd-1 抑制劑之組合治療
TWI794171B (zh)	2016-05-11	2023-03-01	美商滬亞生物國際有限公司	Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療
WO2024077078A2 (en) *	2022-10-05	2024-04-11	The Research Foundation For The State University Of New York	Sterylglucosidase inhibiting compositions and method of using

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1593146A (en) *	1976-11-05	1981-07-15	Beecham Group Ltd	Octahydro-quinolizinyl benzamide derivatives
US4143150A (en) *	1977-08-19	1979-03-06	A. H. Robins Company, Inc.	Derivatives of oxanilic acid
DE2855853C2 (de) *	1978-12-22	1986-09-11	Yamanouchi Pharmaceutical Co., Ltd., Tokio/Tokyo	N-(1-Benzyl-2-methyl-3-pyrrolidinyl)-5-chlor-2-methoxy-4-methylaminobenzamid dessen Säureadditionssalze, Verfahren zu deren Herstellung und ihre Verwendung
GB8718346D0 (en) *	1987-08-03	1987-09-09	Fordonal Sa	Substituted benzamides
IT1216120B (it) *	1988-03-17	1990-02-22	Poli Ind Chimica Spa	Derivati n_cicloalchilaminoetilbenzamidici, loro preparazione e composizioni farmaceutiche che li contengono.

1991
- 1991-10-07 JP JP3326308A patent/JP2529912B2/ja not_active Expired - Fee Related
- 1991-10-11 TW TW080108020A patent/TW228520B/zh active
- 1991-10-16 US US07/777,011 patent/US5143935A/en not_active Expired - Lifetime
- 1991-10-16 DE DE69126758T patent/DE69126758T2/de not_active Expired - Fee Related
- 1991-10-16 ES ES91309528T patent/ES2106058T3/es not_active Expired - Lifetime
- 1991-10-16 EP EP91309528A patent/EP0481756B1/en not_active Expired - Lifetime
- 1991-10-16 DK DK91309528.7T patent/DK0481756T3/da active
- 1991-10-16 KR KR1019910018181A patent/KR100209118B1/ko not_active IP Right Cessation
- 1991-10-16 AT AT91309528T patent/ATE155127T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
KR100209118B1 (ko)	1999-07-15
KR920007995A (ko)	1992-05-27
DK0481756T3 (da)	1998-02-16
US5143935A (en)	1992-09-01
JP2529912B2 (ja)	1996-09-04
EP0481756B1 (en)	1997-07-09
JPH0517434A (ja)	1993-01-26
EP0481756A2 (en)	1992-04-22
ATE155127T1 (de)	1997-07-15
ES2106058T3 (es)	1997-11-01
DE69126758T2 (de)	1998-02-12
DE69126758D1 (de)	1997-08-14
EP0481756A3 (en)	1992-08-26

Publication	Publication Date	Title
SG47986A1 (en)	1998-04-17	A pharmaceutical solution
GR3035148T3 (en)	2001-04-30	Retroviral protease inhibiting compounds.
KR100202474B1 (en)	1999-06-15	Novel tetrapeptide derivative
FI914928A (fi)	1992-04-19	Hydroximetyl (metylencyklopentyl) puriner och -pyrimidiner.
EP0563345A4 (en)	1994-09-28	Novel 4-arylpiperazines and 4-arylpiperidines
SE9100920D0 (sv)	1991-03-27	New active compounds
TW228520B (zh)	1994-08-21
ZA927606B (en)	1993-04-13	Antifungal agent.
IL118367A0 (en)	1996-09-12	Heteroaroyl derivatives
DE69121259D1 (de)	1996-09-19	Beta-Lactam-Verbindungen und ihre Herstellung
DK0566175T3 (da)	1998-01-26	3,4-diaryl-(5H)-furan-2-on-baserede forbindelser med fungicid aktivitet
ATE83377T1 (de)	1993-01-15	Antianaerobe naphthyridinverbindungen.
FI901277A0 (fi)	1990-03-14	2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
ES2093051T3 (es)	1996-12-16	Purinil- y pirimidil-tetrahidrofuranos.
TW265342B (zh)	1995-12-11
CA1270833C (en)	1990-06-26	2,5-PYRROLIDINEDIONE DERIVATIVES USEFUL AS ANTI-ARHYTMIZING AGENTS